BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35197004)

  • 1. Semi-automated histogram analysis of normal bone marrow using
    Satoh Y; Funayama S; Onishi H; Kirito K
    BMC Med Imaging; 2022 Feb; 22(1):31. PubMed ID: 35197004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow segmentation and radiomics analysis of [
    Milara E; Gómez-Grande A; Tomás-Soler S; Seiffert AP; Alonso R; Gómez EJ; Martínez-López J; Sánchez-González P
    Comput Methods Programs Biomed; 2022 Oct; 225():107083. PubMed ID: 36044803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
    Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
    [No Abstract]   [Full Text] [Related]  

  • 8. [
    Dyall J; Johnson RF; Chefer S; Leyson C; Thomasson D; Seidel J; Ragland DR; Byrum R; Jett C; Cann JA; St Claire M; Jagoda E; Reba RC; Hammoud D; Blaney JE; Jahrling PB
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y; Zhou J; Wang L; Li JY; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.
    Sager S; Ergül N; Ciftci H; Cetin G; Güner SI; Cermik TF
    Skeletal Radiol; 2011 Jul; 40(7):843-7. PubMed ID: 21229354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics analysis of bone marrow biopsy locations in [
    Milara E; Alonso R; Masseing L; Seiffert AP; Gómez-Grande A; Gómez EJ; Martínez-López J; Sánchez-González P
    Phys Eng Sci Med; 2023 Jun; 46(2):903-913. PubMed ID: 37155114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Value of
    Liu J; Li C; Yang X; Lu X; Zhang M; Qian L; Wang W; Kan Y; Yang J
    Contrast Media Mol Imaging; 2022; 2022():7556315. PubMed ID: 35082556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge.
    Hsiao YS; Shen SC; Hsiao SC
    Am J Case Rep; 2024 Apr; 25():e943275. PubMed ID: 38644602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.